Global Metabolomics Services Market Size is valued at USD 2.5 Bn in 2024 and is predicted to reach USD 8.6 Bn by the year 2034 at a 13.0% CAGR during the forecast period for 2025 to 2034.
Metabolomics Services Market Size, Share & Trends Analysis Report By Type Of Technique (LC-MS, GC-MS, And NMR), Type Of Service (Targeted & Untargeted Metabolomics ), Applications (Biomarker Discovery, Personalized Medicine, Disease Diagnosis, Drug Discovery And Toxicological Testing), And End-User , By Region, And Segment Forecasts, 2025 to 2034
Key Industry Insights & Findings from the Report:
Metabolomics is a comprehensive study of metabolites. The metabolites produced by the cell during metabolism are collectively called metabolomes. It is an analytical profiling technique for estimating and comparing vast numbers of metabolites in biological samples. Existing metabolomic technologies go well beyond the scope of standard clinical chemistry techniques and can precisely analyze hundreds to thousands of metabolites.
The human body has thousands of metabolites in the human metabolome, which are associated with genetic disorders. This metabolome profiling can assist in a better understanding of diseases and helps to identify new biomarkers for diagnosis and prognosis.
The metabolomics technique can potentially improve the efficacy and rate of drug discovery by employing metabolite detection techniques that comprise identification, quantification, and targeted and untargeted metabolomic profiling. With the help of metabolomics, it is possible to explore the products obtained during metabolic conversions by gut microbiota from dietary components and examine what kind of metabolic alterations they evoke in the circulation and potential target tissues.
The global metabolomics services market is segmented by Type of Technique, Type of Service, applications, and end-user. LC-MS, GC-MS, and NMR are the types of the technique. In comparison, Targeted and untargeted metabolomics are types of the services. By application, the metabolomics services market is divided into biomarker discovery, personalized medicine, disease diagnosis, drug discovery and toxicological testing, which are responsible for overall industry growth. The end-users of the market are research and academic institutes, pharma and biotech firms and CROs. These end-users provide the need for metabolome profiling due to the research advancements.
The diverse need for biomarkers for diagnosis and advanced techniques for drug development & discovery will propel the metabolomics services market. Recognition of chronic diseases with the metabolomic separation method allows healthcare providers to provide effective disease treatment. Rising awareness of the usage of metabolomics techniques among drug developers and application industries as it has more pros and fewer cons.
Moreover, Pharmaceutical companies are raising funds and increasing collaborations with other specialty companies for research, and expanding diagnosing facilities will boost the market growth. The method is cost-effective in the study. In Apr 2022, Creative Proteomics Metabolomics Launched Animal Untargeted Metabolomics Solutions for Scientific Research. This untargeted metabolomic profiling is based on a chromatographic technique and spectrometry platform.
However, increasing the cost of analyzing instruments and maintenance will hamper the services market. Delayed funding, process time and availability of experts will slow down the market growth.
North America will lead the market with substantial investments and more facilities for analyzing the product or materials. It is followed by Europe with different collaborations and partnerships for the developments.
| Report Attribute | Specifications |
| Market size value in 2024 | USD 2.5 Bn |
| Revenue forecast in 2034 | USD 8.6 Bn |
| Growth rate CAGR | CAGR of 13.0% from 2025 to 2034 |
| Quantitative units | Representation of revenue in US$ Bn, and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Type Of Technique, Type Of Service, Applications, And End-User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; ; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Biocrates life sciences ag, Creative Proteomics, DNA Xperts, Eremid Research Services, Human Metabolome Technologies (HMT), Metabo Profile, Metabolon, MS-Omics, Novelgene Technologies, Synbio Technologies, Afekta Technologies Ltd., BASF SE, Chenomx Inc., The Metabolomics Innovation Centre (TMIC), Lipotype GmbH, Metasysx GmbH |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Metabolomics Services Market, by Type of Technique
Global Metabolomics Services Market, by Type of Service
Global Metabolomics Services Market, by Application
Global Metabolomics Services Market, by End-User, 2023-2031
Global Metabolomics Services Market, by Region
North America Metabolomics Services Market, by Country
Europe Metabolomics Services Market, by Country
Asia Pacific Metabolomics Services Market, by Country
Latin America Metabolomics Services Market, by Country
Middle East & Africa Metabolomics Services Market, by Country
Competitive Landscape
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.